Literature DB >> 9070576

Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III.

P J Lee1, J E Deanfield, M Burch, K Baig, W J McKenna, J V Leonard.   

Abstract

A comparison of blood pressure response with exercise stress, thallium scintigraphy, and 24-hour electrocardiographic monitoring between 5 patients with left ventricular hypertrophy associated with glycogen storage disease type III and 10 matched patients with hypertrophic cardiomyopathy revealed normal results in the former group. These data highlight the importance of the etiology of left ventricular hypertrophy before the application of risk stratification.

Entities:  

Mesh：

Year:  1997        PMID： 9070576     DOI： 10.1016/s0002-9149(96)00885-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

1.  Glycogen storage disease type III in Inuit children.

Authors:  Paul James A Zimakas; Celia J Rodd
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

2.  Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.

Authors:  Christiaan P Sentner; Yvonne J Vos; Klary N Niezen-Koning; Bart Mol; G Peter A Smit
Journal:  JIMD Rep       Date:  2012-03-16

3.  Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Authors:  Christiaan P Sentner; Kadir Caliskan; Wim B Vletter; G Peter A Smit
Journal:  JIMD Rep       Date:  2011-12-13

4.  Correction of glycogen storage disease type III with rapamycin in a canine model.

Authors:  Haiqing Yi; Elizabeth D Brooks; Beth L Thurberg; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2014-02-08       Impact factor: 4.599

Review 5.  Preclinical Development of New Therapy for Glycogen Storage Diseases.

Authors:  Baodong Sun; Elizabeth D Brooks; Dwight D Koeberl
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

6.  Blood lipids and endothelial function in glycogen storage disease type III.

Authors:  E Hershkovitz; A Donald; M Mullen; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

7.  Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.

Authors:  Barbara Burwinkel; John W Scott; Christoph Bührer; Frank K H van Landeghem; Gerald F Cox; Callum J Wilson; D Grahame Hardie; Manfred W Kilimann
Journal:  Am J Hum Genet       Date:  2005-05-02       Impact factor: 11.025

Review 8.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

9.  Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Authors:  A I Dagli; R T Zori; H McCune; T Ivsic; M K Maisenbacher; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2009-03-30       Impact factor: 4.982

Review 10.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.